» Articles » PMID: 37234815

Questioning Universal Use of O- Red Blood Cells in Intrauterine Transfusions

Overview
Journal AJOG Glob Rep
Date 2023 May 26
PMID 37234815
Authors
Affiliations
Soon will be listed here.
Abstract

In the setting of maternal alloimmunization to antigen(s) on fetal red blood cells, significant fetal anemia may develop, and an intrauterine transfusion may be required. When selecting a blood product for intrauterine transfusion, the priority should be crossmatch compatibility with the mother. Preventing fetal alloimmunization is not practical or necessary. Universal use of O- red blood cells is not appropriate for pregnant women who are alloimmunized to c or e antigens and require an intrauterine transfusion. Essentially, 100% of people who are D- are homozygous for both c and e antigens. Thus, it is logistically impossible to find red blood cells that is D-c- or D-e-, and O+ red blood cells is necessary in the context of maternal alloimmunization to c or e antigens.

References
1.
Palmeira P, Quinello C, Silveira-Lessa A, Zago C, Carneiro-Sampaio M . IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol. 2012; 2012:985646. PMC: 3251916. DOI: 10.1155/2012/985646. View

2.
La Rocca C, Carbone F, Longobardi S, Matarese G . The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus. Immunol Lett. 2014; 162(1 Pt A):41-8. DOI: 10.1016/j.imlet.2014.06.013. View

3.
Bowell P, Brown S, Dike A, Inskip M . The significance of anti-c alloimmunization in pregnancy. Br J Obstet Gynaecol. 1986; 93(10):1044-8. DOI: 10.1111/j.1471-0528.1986.tb07829.x. View

4.
Moinuddin I, Fletcher C, Millward P . Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan. J Blood Med. 2019; 10:283-289. PMC: 6708388. DOI: 10.2147/JBM.S214118. View

5.
Mari G, Norton M, Stone J, Berghella V, Sciscione A, Tate D . Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8: the fetus at risk for anemia--diagnosis and management. Am J Obstet Gynecol. 2015; 212(6):697-710. DOI: 10.1016/j.ajog.2015.01.059. View